Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2021 | Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection | J.-T. Jan; T.-J. R. Cheng; Y.-P. Juang; H.-H. Ma; Y.-T. Wu; W.-B. Yang; C.-W. Cheng; X. Chen; T.-H. Chou; J.-J. Shie; W.-C. Cheng; R.-J. Chein ; S.-S. Mao; P.-H. Liang; C. Ma; S.-C. Hung; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 118(5), e2021579118 | |||
2015 | Stage-specific embryonic antigen-3 (SSEA-3) and beta3GalT5 are cancer specific and significant markers for breast cancer stem cells | S. K. C. Cheung; P.-K. Chuang; H.-W. Huang; W. W. Hwang-Verslues; C. H.-H. Cho; W.-B. Yang; C.-N. Shen; M. Hsiao; T.-L. Hsu; C.-F. Chang; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 113(4), 960-965 | |||
2016 | Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. | S. K. C. Cheung; P.-K. Chuang; H.-W. Huang; W. W. Hwang-Verslues; C. H.-H. Cho; W.-B. Yang; C.-N. Shen; M. Hsiao; T.-L. Hsu; C.-F. Chang; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 113(4), 960-965 |